Tuesday, January 18, 2011

Cyber knife surgery

Email : cyberknifeindia@yahoo.in
Web : http://www.cyberknife.co.in

CyberKnife Radiosurgery

Email : cyberknifeindia@yahoo.in
Web : http://www.cyberknife.co.in

CyberKnife treatment

Email: cyberknifeindia@yahoo.in
Web : http://www.cyberknife.co.in

CyberKnife in Mumbai

Email: cyberknifeindia@yahoo.in
Web : http://www.cyberknife.co.in

Cyber Knife for Lung Cancer


Email : cyberknifeindia@yahoo.in
Web : http://www.cyberknife.co.in

CyberKnife in India

EMAIL: cyberknifeindia@yahoo.in
Web :  http://www.cyberknife.co.in

CyberKnife : UNDERGO SURGERY WITHOUT GOING UNDER THE KNIFE

A surgery that does not involve incision. This ground breaking technology is now a reality and goes by the name of ‘Cyber Knife’. CyberKnife is the world’s first non-invasive whole-body, Robotic Radio-surgery system. It is designed to treat tumors anywhere in the body with pin – point accuracy. This latest technology has been in a trail phase for some time now, but has recently surfaced across the world as one of the best procedures to treat tumors and cancers in a no-invasive way.
In a nutshell, Cyberknife is a device that corrects, reduces and even eradicates tumor cells in human body through a radiation beam without one having to go under the knife at all. CyberKnife uses pencil beams of radiation which can be directed at any part of the body from any direction via a robotic arm. The robotic arm tracks the tumor’s position, detects any movement of the tumor or patient, and automatically corrects its positioning before targeting the tumor with multiple beams of high-energy radiation. It destroys abnormal tissue without damaging surrounding areas of tumor. The two main elements of the CyberKnife are the radiation produced from a small linear particle accelerator and a robotic arm which allows the energy to be directed at any part of the body from any direction.
The treatment is so accurate that it’s now possible to treat tumors previously thought to be inoperable. It is one of a kind device that owes its credibility and success to technological amendments such as image guidance software to track and continually adjust treatment for any patient or tumor movement, no need for head-frames that screw into patient’s skull in order to avoid movement and an unlimited scope in terms of being able to treat numerous types of tumors of human body including the prostate, lung, brain, spine, liver, pancreas, and kidney.
This procedure has now been widely accepted, even though many patients show resistant to it. But it is definitely a viable solution for terminal cases as it gives a hope for prolonged life. Such use of computer and robotics has resulted in a system that can transform the way tumors and even cancer cells are treated, without affecting other body functions severely.


Email:  cyberknifeindia@yahoo.in

CyberKnife Prostrate Treatment

Study Demonstrates Long-Term Efficacy of Five-Day Course of CyberKnife Prostate Treatment
Accuray Incorporated (NASDAQ:ARAY), a global leader in the field of radiosurgery, announced today the first published five-year outcomes on low risk prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System. The multi-center study, published in the January 10, 2011 issue of Radiation Oncology, found that 93 percent of patients had no recurrence of their cancer at a median follow-up of five years, a rate that compares favorably to results obtained with other treatment modalities, including surgery and conventional radiation therapy.
The study, “Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: Five-Year Outcomes,” combined data from 41 patients treated at Stanford University in Stanford, Calif. and Naples Community Hospital in Naples, Fla. with a median follow-up of five years. The paper represents the longest published study to date on the use of CyberKnife radiosurgery, also referred to as stereotactic body radiotherapy (SBRT), as a treatment approach for clinically localized, low-risk prostate cancer. In addition to demonstrating high five-year disease-free survival rates, the study also found generally low levels of urinary and rectal toxicity following the five-day course of treatment, concluding that CyberKnife radiosurgery can achieve high rates of disease control while sparing critical structures, thereby minimizing undesirable side effects typically associated with prostate cancer treatments and preserving patients’ quality of life.
“As a non-invasive treatment option completed in just five visits, stereotactic radiotherapy with the CyberKnife System offers patients the benefits of more rapid recovery, reduced travel costs and less time off work, allowing them to return to their normal, daily routines almost immediately as compared with the standard nine-week course of radiotherapy,” said Christopher King, M.D., an author on the study who is now an Associate Professor of Radiation Oncology and Urology at the UCLA School of Medicine. “In addition, because CyberKnife radiosurgery costs less than conventional radiation and avoids the anesthesia and hospital stay associated with surgery, our national health care system benefits from reduced health care costs.”
The past 12 months have seen the publication and presentation of numerous shorter term CyberKnife prostate radiosurgery experiences demonstrating encouraging outcomes. This paper supports these outcomes within a long-term follow-up study. Additional this month, the Accuray sponsored multi-center homogeneous prostate study for low and intermediate risk patients, led by the team at the Swedish Cancer Center in Seattle, accrued the final of 294 patients, providing a broad foundation for future long-term multi-center results.
“The publication of five-year clinical outcomes represents a significant milestone for CyberKnife radiosurgery and is important news for physicians to consider when determining the best course of treatment for prostate cancer patients,” said Euan S. Thomson, Ph.D., president and CEO of Accuray. “We look forward to this study and other multi-center studies providing additional long-term quality support of CyberKnife prostate radiosurgery outcomes.”


Email: cyberknifeindia@yahoo.in

Tuesday, January 4, 2011

CyberKnife treatment in India

CyberKnife is a non-invasive alternative to surgery. The source of the therapeutic x-ray (the Linear Accelerator) is mounted on a computer controlled robotic arm. It can aim a pencil-like beam exactly at the target from any direction. This flexibility results in a ‘never seen before’ precision with which beam reaches and destroys the lesion. It is successful in the treatment of cancerous and non-cancerous tumors anywhere in the body, including the prostate, lung, brain, spine, liver, pancreas and kidney

http://www.cyberknife.co.in

cyberknifeindia@yahoo.in

Dr.Sanjay Mongia

CyberKnife treatment

Benefits of CyberKnife Treatment



A new treatment option: this extraordinary sophisticated treatment can be used as an alternative to open surgery. CyberKnife treatment even can often convert a technically inoperable tumor to operable.

Pain free: the treatment does not cause pain.

No anesthesia is required.

Recovery time: a vast majority of CyberKnife treatments are outpatient procedures allowing patients to continue with their daily life.

Comparative comfort: many of the available high precision radiation techniques require some kind of frame to be around the patient’s body; CyberKnife meanwhile, can spare the patient this inconvenience. In many of the cases, it is a frameless procedure.

Lower risk than the conventional surgery

Minimised risk of radiation damage to normal surrounding healthy tissues
 
http://www.cyberknife.co.in
 
Email : cyberknifeindia@yahoo.in
 
Dr.Sanjay Mongia
 

Monday, January 3, 2011

Cyber Knife India

Best Cancer treating technology now in India . CyberKnife is the World's first non-invasive whole-body,Robotic Radiosurgery system .

Read about it at http://www.cyberknife.co.in 

Email :  cyberknifeindia@yahoo.in

Dr.Sanjay Mongia

Cyber Knife

The CyberKnife Robotic Radiosurgery System is a non-invasive alternative to surgery for the treatment of both cancerous and non-cancerous tumors anywhere in body.

Read more abour Cyber knife at  http://www.cyberknife.co.in/

Email:  CYBERKNIFEINDIA@YAHOO.IN

Dr.Sanjay Mongia